Panel Discussion: Demonstrating the Superiority of Bispecifics in Immuno-Oncology Indications in Comparison with Antibody Combinations

Time: 9:50 am
day: Day Two


  • Exploring the pros and cons of pursuing bispecific constructs in comparison with combination approaches
  • Examining the potential novel biologies that are opened up by utilizing multispecific approaches
  • Identifying scenarios in which bispecifics can add the most value and show significant superiority over alternative approaches